Acupuncture or Metformin for Insulin Resistance in Women With PCOS

Recruiting Phase 2 Interventional Study
Polycystic Ovary Syndrome Insulin Resistance Hyperandrogenism
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Female
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
303 (estimated)
Sponsor
Karolinska Institutet · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The hypothesis is that acupuncture is equally effective as metformin (both treatments combined with lifestyle management) in improving whole body glucose homeostasis in insulin resistant women with polycystic ovary syndrome (PCOS), and that both are superior to lifestyle management alone. The investigators hypothesize that acupuncture and metformin induce ovulation and improve hyperandrogenism, as…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria - women with PCOS: 1. Age 18 to 40 years 2. Body mass index (BMI) ≥25 to ≤40 given that 95% of all women with PCOS with a BMI ≥25 are insulin resistant (71,72). 3. PCOS diagnosis according to Rotterdam criteria 2003 (73), with at least two of the following three symptoms: Clinica…
Contacts

Elisabet Stener-Victorin, PhD

+46705643655

elisabet.stener-victorin@ki.se

CONTACT

Berit Legerstam, Study nurse

+46851773782

berit.legerstam@karolinska.se

CONTACT